Embecta
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
300 Kimball Dr Ste 300, Parsippany, New ...Phone Number
(862) 401-0000Website
www.embecta.comRevenue
$1 BillionStock Symbol
EMBCIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
8
1
2
1
1
About Embecta
Embecta is a company that specializes in the manufacturing of medical equipment that is used to help treat diabetes. The company is based in Franklin Lakes, New Jersey.Explore more
Embecta Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Embecta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Embecta has new funding data
Embecta, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Embecta
Check if Embecta has recently received funding, and reach out quickly before it becomes old news!
Click to see if Embecta had a recent Job posting/layoffs
Earning: See what the market has to say on Embecta recently announced quarterly report
Check out if Embecta is spiking on competitors!
Product Launch: Get notified when Embecta launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Embecta
Compare insights from companies similar to Embecta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Embecta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Embecta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Embecta.
Embecta Tech Stack
A closer look at the technologies used by Embecta
See more technologies
Most Recent Scoops
Project
Embecta has highlighted Owen Mumford's R&D expertise in the drug delivery space, including the development of a novel auto-injector adapter that offers pharmaceutical companies manufacturing flexibility while preserving patient-centric features.
Acquisitions
Project
Embecta has announced that its new syringe has achieved its first commercial sale in China, with regulatory approvals expected to expand distribution globally.
Pain Point
Embecta is facing external market headwinds as GLP-1 products became significantly more affordable in late calendar year, and ACA subsidies expired, with initial reports indicating approximately 1 million fewer enrollees and more recent reports suggesting the number could be substantially larger.
Barriers
Earnings
Embecta has reported a reduction in its quarterly dividend from $0.15 per share to $0.01 per share.
Accounting, Financial Reporting, Business Finance, Finance
Earnings
Share Placement, Finance, Financing & Debt
Embecta News & Media
Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, June 29, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC) common stock between November 25, 2025 and May 4, 2026, inclusive (the “Class Period”).Investor Announcement: Embecta Investors are Notified to Contact BFA Law about the Pending Securities Fraud Class Action to Recover Stock Losses
Embecta Investors are Notified to Contact BFA Law about the Pending Securities Fraud Class Action to Recover Stock LossesBragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Embecta Corp. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Embecta (EMBC) To Contact Him Directly To Discuss Their OptionsBronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Embecta (EMBC) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/17/2026
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Embecta
Sign Up For FreeTo access detailed company insights
Embecta is a company that specializes in the manufacturing of medical equipment that is used to help treat diabetes. The company is based in Franklin Lakes, New Jersey.... Read More
